News
See the latest in our fight to end neurodegenerative disease.
-
READ MORE
Libra Therapeutics Appoints Dr. Shawn A. Scranton as President and Chief Executive Officer
-
READ MORE
Libra Therapeutics Appoints Gene Kinney, Ph.D., Chairperson of the Company’s Board of Directors
-
READ MORE
John Renger, Ph.D., Appointed to Libra’s Scientific Advisory Board
-
READ MORE
Libra Therapeutics Appoints Gene Kinney, Ph.D., to Its Board of Directors
-
READ MORE
Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases